This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

Amani Therapeutics Form D (2026)

Amani Therapeutics reported $34,999,999 raised in an SEC Form D filed on 2026-10-01.

Company
Amani Therapeutics
Round type
Form D
Date
2026-10-01
Amount
$35M
Industry
Other Health Care
Location
New York

Summary

The SEC Form D for Amani Therapeutics, filed on 2026-10-01, reports $34,999,999 raised. It was listed in the Raise Track Update of 2026-10-05. Filing: https://www.sec.gov/Archives/edgar/data/2099941/000209994126000002/0002099941-26-000002-index.htm

This page is not indexed by search engines yet because the filing is its only source.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/2099941/000209994126000002/0002099941-26-000002-index.htm
    Type: sec filing. Accessed 2026-10-12.
    SEC Form D filed 2026-10-01 by Amani Therapeutics, Inc. Reports $34,999,999 of securities sold. It does not name investors or a round type.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-05/
    Type: other verified public source. Accessed 2026-10-12.
    Raise Track Update for 2026-10-05, Section 3 (SEC Form D filings). Lists Amani Therapeutics, state NEW YORK, industry Other Health Care, amount raised $34,999,999.